Immune‐based transcriptomic signature predicts CDK4/6 inhibitor efficacy in HR+/HER2– breast cancer by Eudald Felip, Edurne Garcia‐Vidal, Sara Cabrero‐de las Heras, Adrià Bernat‐Peguera, Beatriz Cirauqui, Milana Bergamino, Vanesa Quiroga, Iris Teruel, Angelica Ferrando‐Díez, Anna Pous, Assumpció Lopez‐Paradís, Laia Boronat, Marga Romeo, Ricard Mesía, Pedro Luis Fernandez, Bonaventura Clotet, Eva Riveira‐Muñoz, Anna Martínez‐Cardús, Ester Ballana, Mireia Margelí

Get full text